ACON
vs
S&P 500
ACON
S&P 500
Over the past 12 months, ACON has underperformed S&P 500, delivering a return of -99% compared to the S&P 500's +12% growth.
Stocks Performance
ACON vs S&P 500
Performance Gap
ACON vs S&P 500
Performance By Year
ACON vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Aclarion Inc
Glance View
Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in San Mateo, California. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and artificial intelligence (AI) technology to optimize clinical treatments. The Company’s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Its first commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. NOCISCAN is a software as a service (SaaS) platform to leverage MRS to non-invasively help physicians distinguish between painful and nonpainful discs in the spine. The platform used to conduct a NOCISCAN-LS involves NOCISCAN-LS MRS exam protocol, data transfer, and the NOCISCAN-LS post-processor suite. The Company’s NOCISCAN-LS post processor suite is comprised of two software products, such as NOCICALC-LS and NOCIGRAM.
